Forough Abbasi

668 total citations
15 papers, 173 citations indexed

About

Forough Abbasi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Reproductive Medicine. According to data from OpenAlex, Forough Abbasi has authored 15 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Reproductive Medicine. Recurrent topics in Forough Abbasi's work include Cancer Mechanisms and Therapy (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer-related molecular mechanisms research (2 papers). Forough Abbasi is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer-related molecular mechanisms research (2 papers). Forough Abbasi collaborates with scholars based in United States and Iran. Forough Abbasi's co-authors include Johnathan M. Lancaster, Robert M. Wenham, Yin Xiong, Douglas C. Marchion, Patricia L. Judson, Ingrid Ramírez, Anders Berglund, Ardeshir Hakam, Sachin M. Apte and Stephen Bush and has published in prestigious journals such as Cancer Research, American Journal of Obstetrics and Gynecology and Cell Reports.

In The Last Decade

Forough Abbasi

15 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Forough Abbasi United States	7	114	46	42	40	25	15	173
Yingwen Zhang China	9	117 1.0×	29 0.6×	17 0.4×	26 0.7×	35 1.4×	25	196
Chinami Makii Japan	6	99 0.9×	46 1.0×	25 0.6×	49 1.2×	16 0.6×	7	167
E Bai China	8	114 1.0×	35 0.8×	63 1.5×	22 0.6×	29 1.2×	14	272
Meenu Maan United Arab Emirates	7	177 1.6×	47 1.0×	79 1.9×	140 3.5×	47 1.9×	10	367
Yuanguang Meng China	8	146 1.3×	16 0.3×	62 1.5×	73 1.8×	46 1.8×	17	303
Kaijiang Liu China	6	114 1.0×	21 0.5×	18 0.4×	65 1.6×	10 0.4×	19	176
Mohamed Hamdy Egypt	5	59 0.5×	48 1.0×	12 0.3×	31 0.8×	10 0.4×	17	148
Waise Quarni United States	7	107 0.9×	48 1.0×	18 0.4×	50 1.3×	17 0.7×	9	211
Hiroshi Kondoh Japan	9	208 1.8×	40 0.9×	14 0.3×	92 2.3×	17 0.7×	16	311
Adriana C. Rodriguez United States	5	139 1.2×	62 1.3×	57 1.4×	88 2.2×	47 1.9×	7	326

Countries citing papers authored by Forough Abbasi

Since Specialization

Citations

This map shows the geographic impact of Forough Abbasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Forough Abbasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Forough Abbasi more than expected).

Fields of papers citing papers by Forough Abbasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Forough Abbasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Forough Abbasi. The network helps show where Forough Abbasi may publish in the future.

Co-authorship network of co-authors of Forough Abbasi

This figure shows the co-authorship network connecting the top 25 collaborators of Forough Abbasi. A scholar is included among the top collaborators of Forough Abbasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Forough Abbasi. Forough Abbasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hashemi, Mehrdad, Nafiseh Sharifi, Khashayar Esfahani, et al.. (2025). SIRT1 as a masterful reciprocal regulator of molecular mechanisms and signaling pathways involved in tumor growth and expansion. Clinical and Experimental Medicine. 25(1). 225–225. 2 indexed citations

Dinh, Huy Q., Xianzhi Lin, Forough Abbasi, et al.. (2021). Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube. Cell Reports. 35(2). 108978–108978. 50 indexed citations

Dinh, Huy Q., Xianzhi Lin, Forough Abbasi, et al.. (2021). Abstract PO023: Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube. Cancer Research. 81(5_Supplement). PO023–PO023. 1 indexed citations

Bush, Stephen, Douglas C. Marchion, Yin Xiong, et al.. (2016). Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Molecular and Clinical Oncology. 4(3). 399–404. 7 indexed citations

Marchion, Douglas C., Elona Biçaku, Forough Abbasi, et al.. (2015). BAD-mediated apoptotic pathway is associated with human cancer development. International Journal of Molecular Medicine. 35(4). 1081–1087. 42 indexed citations

Xiong, Yin, Douglas C. Marchion, Forough Abbasi, et al.. (2015). Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance. Gynecologic Oncology. 140(2). 259–263. 16 indexed citations

Ramírez, Ingrid, Douglas C. Marchion, Yin Xiong, et al.. (2015). Repurposing Artesunate, an anti-malarial, for ovarian cancer treatment: Mechanistic insights from cell line models. Gynecologic Oncology. 137. 207–207. 2 indexed citations

Marchion, Douglas C., Yin Xiong, Ingrid Ramírez, et al.. (2014). The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest. Journal of Cancer Research and Clinical Oncology. 141(2). 237–242. 27 indexed citations

Xiong, Yin, Douglas C. Marchion, Forough Abbasi, et al.. (2014). Development of a rucaparib response signature that shows in vitro predictive value to the PARP inhibitors, ABT-888 and olaparib in ovarian cancer cells. Gynecologic Oncology. 133. 22–22. 1 indexed citations

10.

Abbasi, Forough, Douglas C. Marchion, Yin Xiong, et al.. (2014). HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity. Gynecologic Oncology. 133. 122–123. 4 indexed citations

11.

Chen, Xin, Douglas C. Marchion, Yin Xiong, et al.. (2013). Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest. Gynecologic Oncology. 131(1). 207–212. 8 indexed citations

12.

Marchion, Douglas C., Yin Xiong, Hye Sook Chon, et al.. (2013). Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer. American Journal of Obstetrics and Gynecology. 209(6). 576.e1–576.e16. 10 indexed citations

13.

Marchion, Douglas C., et al.. (2013). An innovative in silico method to identify agents that target pathways of human cancer chemoresistance. Gynecologic Oncology. 130(1). e161–e161. 1 indexed citations

14.

Marchion, Douglas C., et al.. (2013). A novel strategy to identify ovarian cancer molecular signaling pathways and drug repurposing candidates. Gynecologic Oncology. 130(1). e4–e4. 1 indexed citations

15.

Marchion, Douglas C., Yin Xiong, Forough Abbasi, et al.. (2013). Molecular characterization of polyphyllin D, a Chinese herb that sensitizes ovarian cancers cells to platinum therapy. Gynecologic Oncology. 130(1). e131–e132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact